• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Video

March 7, 2024

Clinical Pharmacist Specialists Are Providing Disease-Specific Support For GI-Related Malignancies

“I see clinical pharmacy specialists (CPS) to be more like the frontline folks that would pretty much work very closely with the providers,” according to a CPS at City of Hope.

In observance of Colorectal Cancer Awareness Month, Elvis Sampson, PharmD, BCPS, the pharmacy operations supervisor at City of Hope, Los Angeles, California, joins Pharmacy Times to discuss the role of the clinical pharmacist specialist (CPS) as part of an interdisciplinary team caring for oncology patients with gastrointestinal (GI)-related malignancies. Sampson also discusses integrating medical oncology modules into the electronic medical record to promote supportive care, and so much more.

PT Staff: What differentiates a clinical pharmacist specialist (CPS) from other types of pharmacists in the oncology setting?

Elvis Sampson, PharmD, BCPS: These pharmacists operate at a very high level of clinical practice, and they provide disease specific support in the various areas of specialty. Because of the clinical expertise that they have, it helps provide them with that unique opportunity of working very closely with the patients, with the providers, [and with] other members of the healthcare team. This helps ensure that there's continuity in the care that they give and ensure that everything aligns with what is actually currently staked.

I see them to be more like the frontline folks that would pretty much work very closely with the providers and be able to, at the very first glance, make sure that any treatment that a patient is supposed to get is a guideline therapy. And we're also looking at things like insurance and authorizations.

PT Staff: How is the implementation of clinical pharmacists, specialists at City of Hope, changing the practicum of care for patients, specifically, with GI-related malignancies?

Image Credit: SciePro - stock.adobe.com

Image Credit: SciePro - stock.adobe.com

Elvis Sampson, PharmD, BCPS: Our clinical pharmacist specialists are very highly valued by our multidisciplinary team. And due to the collaborative work they do, [they] help all of our patients get on the path to better health.

For example, they join a team during interdisciplinary rounds. They help make appropriate recommendations where it's necessary. They help thoroughly review [the] provider’s medication orders and make sure it's very appropriate. They'll also help in processing non-formulary drug requests. They help a lot to make sure that all the documentation or the necessary paperwork is in place. They also help provide education to pharmacy and other non-pharmacy teams. So think about the nursing team even provide us. And another important aspect is they also help to promote cost-effective, quality care. Because these oncology treatments can be very, very expensive, we can prevent any unnecessary drugs put away, or [help to] choose the best possible drug there has the easy cost.

PT Staff: How is Epic Beacon used, and how does its integration with the electronic medical record (EMR) improve treatment efficacy and patient safety?

Elvis Sampson, PharmD, BCPS: Now, this module provides the end user (that's the providers and nurses, pharmacists) [with] that ease of documentation when it comes to the patient's cancer stage and choosing the appropriate treatment plans. And again, talking about treatment plans, Epic Beacon gives you the opportunity to pretty much have prebuilt treatment plans.

So, when I say prebuilt treatment plans— let's say we're looking at a GI-related malignancy— we’re able to build those treatment plans and go to PNT approval and go through medical executive committee approval (and that's already reviewed thoroughly) and it's pretty much already there and ready to be used.

You could have a plethora of these treatment plans, so you don't have to go to stage 1 to try to put things together what pre-medications a patient needs, what supportive care does the patient need, what is the communication to the provider, [and] patients pay less and less. And everything is prebuilt. It also helps you to track the ordering, the distribution, and administration of these oncologic products. So it's a very, very useful module and it makes life easy.

PT Staff: Are there any medications, services, and opportunities that clinical pharmacist should keep their eye on in regard to the treatment and management of colorectal cancer?

Elvis Sampson, PharmD, BCPS: So I always say there's always lots and lots and lots of opportunities out there for pharmacists, and just keep abreast of the information that's out there because oncology is very dynamic. It's always changing. It's every single day a new drug is coming out every single day a new study [or] trial is coming out. So it's always in the interest of the pharmacist to just sign up. And obviously, it's always good to sign up with some of these news alerts to be able to know, “Hey, there's a new drug out there, there's a new post marketing survey [or] there's a new Blackbox warning.” It keeps you updated.

And with the role a clinical pharmacist specialist is playing, we're able to reach out to even providers and let them know that “Hey, you know, just recently this information about this drug came out and this is a good thing. There's a new study that you can combine “this” with another thing,” etc… then 1 thing leads to another, and it has to go through a committee to see if we can update the treatment plans or make any changes that pretty much would affect the patient in a positive manner.

PT Staff: So my last question I do want to ask is, because it's going to be Colorectal Cancer Awareness Month in March, is there anything that you would like pharmacists, providers, or even the layman to know about this disease and the treatment of it?

Elvis Sampson, PharmD, BCPS: Just make sure you know if there's anything that looks out of the ordinary, [if] there's anything that is not looking like what is supposed to be, just reach out. The earlier the better. Reach out to your provider, do all the necessary testing that's supposed to be done. This is something that can be prevented right from the early stage.

PT Staff: Is there anything else you'd like to add?

Elvis Sampson, PharmD, BCPS: I just want to say thank you for this opportunity to be able to speak on these very important topics, describing what a CPS does and see how pharmacists are helping to streamline care. It's a great opportunity and I know with similar things like this, the world is going to keep hearing us more and more and we can all be on that path…to always better health.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Related Content
Advertisement
X-ray image of kidneys with CKD -- Image credit: Crystal light | stock.adobe.com
July 2nd 2025

FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related Hyperphosphatemia

Gillian McGovern, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
pores on the skin of the face. Cleansing the face skin - Image credit: Angelina | stock.adobe.com
July 2nd 2025

Study Examines How Vitamin C Shapes Skin Health Through TET-Mediated Demethylation

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
3d illustration of the heart and lung
July 2nd 2025

Lung Transplant Recipients at High Risk of Secondary Lung Infections Post-Infection With SARS-CoV-2 Omicron Variant

Luke Halpern, Assistant Editor
Microscopic view of bone marrow slide feature are suggestive Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
Published: July 2nd 2025 | Updated: July 2nd 2025

FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma

Luke Halpern, Assistant Editor
Related Content
Advertisement
X-ray image of kidneys with CKD -- Image credit: Crystal light | stock.adobe.com
July 2nd 2025

FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related Hyperphosphatemia

Gillian McGovern, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
pores on the skin of the face. Cleansing the face skin - Image credit: Angelina | stock.adobe.com
July 2nd 2025

Study Examines How Vitamin C Shapes Skin Health Through TET-Mediated Demethylation

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
3d illustration of the heart and lung
July 2nd 2025

Lung Transplant Recipients at High Risk of Secondary Lung Infections Post-Infection With SARS-CoV-2 Omicron Variant

Luke Halpern, Assistant Editor
Microscopic view of bone marrow slide feature are suggestive Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
Published: July 2nd 2025 | Updated: July 2nd 2025

FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.